Novartis Europharm Limited
- A10 - Antidiabéticos
- EUCREAS film-coated tablet 1 000 mg+50 mg
- EUCREAS film-coated tablet 850 mg+50 mg
- JALRA tablet 50 mg
- METFORMIN AND VILDAGLIPTIN film-coated tablet 1 000 mg+50 mg
- TRAZEC film-coated tablet 120 mg
- TRAZEC film-coated tablet 60 mg
- C09 - Agentes activos sobre el sistema renina-angiotensina
- COPALIA film-coated tablet 160 mg+10 mg
- COPALIA film-coated tablet 160 mg+5 mg
- COPALIA film-coated tablet 80 mg+5 mg
- DAFIRO film-coated tablet 160 mg+10 mg
- DAFIRO film-coated tablet 160 mg+5 mg
- DAFIRO film-coated tablet 80 mg+5 mg
- ENVIAGE film-coated tablet 150 mg
- ENVIAGE film-coated tablet 300 mg
- EXFORGE film-coated tablet 160 mg+10 mg
- EXFORGE film-coated tablet 160 mg+5 mg
- EXFORGE film-coated tablet 80 mg+5 mg
- IMPRIDA film-coated tablet 160 mg+10 mg
- IMPRIDA film-coated tablet 160 mg+5 mg
- IMPRIDA film-coated tablet 80 mg+5 mg
- RASILEZ film-coated tablet 150 mg
- RASILEZ film-coated tablet 300 mg
- RIPRAZO film-coated tablet 150 mg
- RIPRAZO film-coated tablet 300 mg
- SPRIMEO film-coated tablet 150 mg
- SPRIMEO film-coated tablet 300 mg
- TEKTURNA film-coated tablet 150 mg
- TEKTURNA film-coated tablet 300 mg
- G04 - Urológicos
- EMSELEX prolonged-release tablet 15 mg
- EMSELEX prolonged-release tablet 7.5 mg
- H01 - Hormonas hipofisiarias, hipotalámicas y análogos
- SIGNIFOR solution for injection 0.3 mg/1 ml
- SIGNIFOR solution for injection 0.6 mg/1 ml
- SIGNIFOR solution for injection 0.9 mg/1 ml
- L01 - Antineoplásicos
- JAKAVI tablet 15 mg
- JAKAVI tablet 20 mg
- JAKAVI tablet 5 mg
- TASIGNA capsule, hard 200 mg
- L03 - Inmunoestimulantes
- EXTAVIA powder and solvent for solution for injection 750 µg+3 ml
- N06 - Psicoanalépticos
- EXELON transdermal patch 4.6 mg/24 h
- EXELON transdermal patch 9.5 mg/24 h
- PROMETAX capsule, hard 1.5 mg
- PROMETAX capsule, hard 3 mg
- PROMETAX capsule, hard 4.5 mg
- PROMETAX capsule, hard 6 mg
- PROMETAX oral solution 2 mg/ml
- PROMETAX transdermal patch 4.6 mg/24 h
- PROMETAX transdermal patch 9.5 mg/24 h
- R03 - Agentes contra padecimientos obstructivos de las vías respiratorias
- ONBREZ BREEZHALER inhalation powder, hard capsule 150 µg
- ONBREZ BREEZHALER inhalation powder, hard capsule 300 µg
- XOLAIR powder and solvent for solution for injection 150 mg+2 ml
- XOLAIR powder and solvent for solution for injection 75 mg+2 ml
- S01 - Oftalmológicos
- LUCENTIS solution for injection 3 mg/0.3 ml